FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095969107> ?p ?o ?g. }

• W3095969107 endingPage "589" @default.
• W3095969107 startingPage "580" @default.
• W3095969107 abstract "Brain metastases are a common and severe complication potentially leading to death in patients with metastatic melanoma. Immunotherapy and targeted therapy have significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced melanoma. Few studies focus on patients with central nervous system (CNS) metastases, and these patients are often excluded and have a poor prognosis. It has been suggested that immunotherapy could reduce the incidence of brain metastases. We tested this hypothesis in a retrospective bicentric study. We performed a retrospective, bicentric descriptive analysis on a cohort of 293 patients treated for metastatic melanoma between May 2014 and October 2017 (Toulouse, N = 202; Limoges, N = 91). Patients with brain metastasis at diagnosis were excluded from the analysis. Patients were separated into two groups according to the first line of treatment: immunotherapy [immune checkpoint inhibitor (ICI)] vs other and anti-PD-1 vs other. The primary endpoint was the cumulative incidence of brain metastases, and secondary endpoints were OS and PFS. At 12 months, the cumulative incidence of brain metastases was 13.78% in the ICI group [95% confidence interval (CI) 9.14–19.36] and 27.26% in the other group (95% CI 19.38–35.71), P = 0.004. The cumulative incidence was 9.49% in the anti-PD-1 group (95% CI 5.43–14.90) vs 30.11% in the other group (95% CI 22.59–37.97), P < 0.0001. In multivariable analysis (model with 277 patients), anti-PD-1 reduced the risk of brain metastases by almost 70% (hazard ratio = 0.29, 95% CI 0.15–0.56, P < 0.0001). The use of ICI (anti-PD-1/PD-L1) in advanced melanomas without initial brain metastasis shows a protective effect and prevents their occurrence." @default.
• W3095969107 created "2020-11-09" @default.
• W3095969107 creator A5003496665 @default.
• W3095969107 creator A5007368768 @default.
• W3095969107 creator A5011047331 @default.
• W3095969107 creator A5012207107 @default.
• W3095969107 creator A5020447288 @default.
• W3095969107 creator A5057663343 @default.
• W3095969107 creator A5067794998 @default.
• W3095969107 creator A5068479125 @default.
• W3095969107 creator A5082390042 @default.
• W3095969107 creator A5084563899 @default.
• W3095969107 creator A5089271242 @default.
• W3095969107 date "2020-12-01" @default.
• W3095969107 modified "2023-10-14" @default.
• W3095969107 title "PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma" @default.
• W3095969107 cites W1968221752 @default.
• W3095969107 cites W1996566286 @default.
• W3095969107 cites W2047241677 @default.
• W3095969107 cites W2056648757 @default.
• W3095969107 cites W2067893090 @default.
• W3095969107 cites W2070825440 @default.
• W3095969107 cites W2152897456 @default.
• W3095969107 cites W2520633772 @default.
• W3095969107 cites W2620651944 @default.
• W3095969107 cites W2743231964 @default.
• W3095969107 cites W2763121409 @default.
• W3095969107 cites W2794627893 @default.
• W3095969107 cites W2797309423 @default.
• W3095969107 cites W2886076079 @default.
• W3095969107 cites W2888298425 @default.
• W3095969107 cites W2891790933 @default.
• W3095969107 cites W2902840691 @default.
• W3095969107 cites W2976532500 @default.
• W3095969107 cites W2981669912 @default.
• W3095969107 cites W4235044653 @default.
• W3095969107 cites W4243716084 @default.
• W3095969107 cites W4256631179 @default.
• W3095969107 doi "https://doi.org/10.1097/cmr.0000000000000700" @default.
• W3095969107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33156203" @default.
• W3095969107 hasPublicationYear "2020" @default.
• W3095969107 type Work @default.
• W3095969107 sameAs 3095969107 @default.
• W3095969107 citedByCount "4" @default.
• W3095969107 countsByYear W30959691072021 @default.
• W3095969107 countsByYear W30959691072022 @default.
• W3095969107 countsByYear W30959691072023 @default.
• W3095969107 crossrefType "journal-article" @default.
• W3095969107 hasAuthorship W3095969107A5003496665 @default.
• W3095969107 hasAuthorship W3095969107A5007368768 @default.
• W3095969107 hasAuthorship W3095969107A5011047331 @default.
• W3095969107 hasAuthorship W3095969107A5012207107 @default.
• W3095969107 hasAuthorship W3095969107A5020447288 @default.
• W3095969107 hasAuthorship W3095969107A5057663343 @default.
• W3095969107 hasAuthorship W3095969107A5067794998 @default.
• W3095969107 hasAuthorship W3095969107A5068479125 @default.
• W3095969107 hasAuthorship W3095969107A5082390042 @default.
• W3095969107 hasAuthorship W3095969107A5084563899 @default.
• W3095969107 hasAuthorship W3095969107A5089271242 @default.
• W3095969107 hasConcept C120665830 @default.
• W3095969107 hasConcept C121332964 @default.
• W3095969107 hasConcept C121608353 @default.
• W3095969107 hasConcept C126322002 @default.
• W3095969107 hasConcept C141071460 @default.
• W3095969107 hasConcept C143998085 @default.
• W3095969107 hasConcept C167135981 @default.
• W3095969107 hasConcept C168563851 @default.
• W3095969107 hasConcept C203092338 @default.
• W3095969107 hasConcept C2777658100 @default.
• W3095969107 hasConcept C2777701055 @default.
• W3095969107 hasConcept C2778164965 @default.
• W3095969107 hasConcept C2779013556 @default.
• W3095969107 hasConcept C2994587330 @default.
• W3095969107 hasConcept C44249647 @default.
• W3095969107 hasConcept C502942594 @default.
• W3095969107 hasConcept C61511704 @default.
• W3095969107 hasConcept C71924100 @default.
• W3095969107 hasConcept C72563966 @default.
• W3095969107 hasConcept C88879693 @default.
• W3095969107 hasConcept C90924648 @default.
• W3095969107 hasConceptScore W3095969107C120665830 @default.
• W3095969107 hasConceptScore W3095969107C121332964 @default.
• W3095969107 hasConceptScore W3095969107C121608353 @default.
• W3095969107 hasConceptScore W3095969107C126322002 @default.
• W3095969107 hasConceptScore W3095969107C141071460 @default.
• W3095969107 hasConceptScore W3095969107C143998085 @default.
• W3095969107 hasConceptScore W3095969107C167135981 @default.
• W3095969107 hasConceptScore W3095969107C168563851 @default.
• W3095969107 hasConceptScore W3095969107C203092338 @default.
• W3095969107 hasConceptScore W3095969107C2777658100 @default.
• W3095969107 hasConceptScore W3095969107C2777701055 @default.
• W3095969107 hasConceptScore W3095969107C2778164965 @default.
• W3095969107 hasConceptScore W3095969107C2779013556 @default.
• W3095969107 hasConceptScore W3095969107C2994587330 @default.
• W3095969107 hasConceptScore W3095969107C44249647 @default.
• W3095969107 hasConceptScore W3095969107C502942594 @default.
• W3095969107 hasConceptScore W3095969107C61511704 @default.
• W3095969107 hasConceptScore W3095969107C71924100 @default.

• next